DBV Technologies Stock (NASDAQ: DBVT) stock price, news, charts, stock research, profile.
Open | $0.74 |
Close | $0.73 |
Volume / Avg. | 9.36K / 45.30K |
Day Range | $0.70 - $0.80 |
52 Wk Range | 0.50 - 5.94 |
Market Cap | $70.44M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 0.37% |
Days to Cover | 17.18 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of DBV Technologies (NASDAQ:DBVT) through any online brokerage.
Other companies in DBV Technologies’s space includes: Connect Biopharma Hldgs (NASDAQ:CNTB), Intensity Therapeutics (NASDAQ:INTS), Cellectar Biosciences (NASDAQ:CLRB), Immuneering (NASDAQ:IMRX) and Armata Pharmaceuticals (AMEX:ARMP).
DBV Technologies has a consensus price target of $3.67.
The stock price for DBV Technologies (NASDAQ: DBVT) is $0.73 last updated September 19, 2024 at 3:58 PM EDT.
There are no upcoming dividends for DBV Technologies.
DBV Technologies’s Q3 earnings are confirmed for Tuesday, October 29, 2024.
There is no upcoming split for DBV Technologies.
DBV Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.